Global pruritus therapeutics market is expected to
reach USD 16.38 Billion by 2025, according to a new study by Grand View
Research, Inc. Growing worldwide prevalence of atopic dermatitis, allergic
contact dermatitis, and urticaria is expected to drive market growth during the
forecast period. The introduction of new products based on scientific
mechanistic understanding such as the identification of new T-cell subsets,
particularly Th17, and Th22 and the patent expiration of PROTOPIC (tacrolimus)
is expected to open up new avenues for manufacturers to capitalize on over the
forecast period.
Corticosteroids were the leading
product segment in 2013 owing to high efficacy exhibited by this class of drugs
in treating pruritic conditions by reducing inflammation and itching. Topical
applications of corticosteroids have been found to be extremely effective in
the treatment and maintenance therapies pertaining to pruritus.
For Full Research Report On Pruritus Therapeutics Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/pruritus-therapeutics-market
Further key
findings from the study suggest:
- Calcineurin inhibitor is
identified as the most lucrative segment of the market on account of the
high usage rate of these drugs in combination therapy for the treatment of
pruritus in patients suffering from chronic pruritus and growing market
penetration rates. Moreover, the introduction of new products such as
Pimecrolimus cream and Tacrolimus ointment is expected to further drive
this market.
- Anti-histamines owing to its
growing use as a first-line treatment and presence of drugs in pipeline
with expected commercialization is also expected to grow at a healthy rate
during the forecast period.
- North America led the
overall market in terms of revenue in 2013 majorly on account of the
presence of a high prevalence of diseases associated with pruritus, the
introduction of new products targeting the unmet medical needs, and
growing patient awareness levels.
- The Asia Pacific pruritus
therapeutics market is expected to grow at a CAGR of over 5.0% during the
forecast period. The presence of high unmet healthcare needs and
increasing prevalence of allergic contact dermatitis and urticaria in this
region are some factors attributing to its rapid growth rate.
- Some key participants of the
pruritus therapeutics market include Sanofi, Pfizer, Tai Guk
Pharmaceutical Company, Actavis, Trevi Therapeutics, Cara Therapeutics,
Ocera Therapeutics Inc. and NeRRe Therapeutics.
- Manufacturers adhere to
rigorous R&D in an attempt to develop cost-effective products and
avoid barriers such as product recalls. In addition, this strategy is
implemented keeping the unmet needs into consideration. For Instance,
Creabilis has a molecule in the pipeline – CT327, which caters to the
unmet needs associated with pruritus in patients suffering from
psoriasis.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/pruritus-therapeutics-market/request/rs1
Grand View Research has segmented
the global pruritus therapeutics market on the basis of product, disease type,
and region:
Global Pruritus
Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)
- Corticosteroids
- Antihistamines
- Local Anesthetics
- Counterirritants
- Immunosuppressant
- Calcineurin Inhibitors
- Others
Global Pruritus
Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)
- Atopic Dermatitis
- Allergic Contact Dermatitis
- Urticaria
- Others
Global Pruritus
Therapeutics Regional Outlook (Revenue, USD Million, 2012 - 2025)
- North America
- The U.S.
- Rest of North America
- Europe
- Germany
- The U.K.
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- Rest of Asia Pacific
- RoW
About Grand View Research
Grand View Research, Inc. is a U.S. based
market research and consulting company, registered in the State of California
and headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment